Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Nektar/BMS Deal Takes Second Gut Punch As IL-2/PD-1 Combo Goes Down In Flames
Apr 15 2022
•
By
Alaric DeArment
Nektar/BMS said they would halt bempeg/Opdivo combination studies • Source: Alamy
More from Deals
More from Business